# Integra Lifesciences Holdings Corp: Form 8-K, filed Oct 19, 2026

- Company: [Integra Lifesciences Holdings Corp](/companies/iart.md) (CIK 917520)
- Form: 8-K
- Filed: 2026-10-19
- Accepted by EDGAR: Oct 19, 2026, 20:20 ET
- Period: 2026-10-19
- Accession: 0001193125-26-425271
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/917520/000119312526425271/d142199d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/917520/000119312526425271/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.03: New direct financial obligation
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/917520/000119312526425271/d142199d8k.htm

Filed Oct 19, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-425271. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.